Mutations to GJB3, GJB4, and GJA1 are linked to erythrokeratodermia variabilis et progressiva (EKVP), a disease characterized by hyperkeratotic plaques and erythematous patches (Ishida-Yamamoto, 2016). Here, GJB3 is linked to erythrokeratodermia variabilis.